Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression is a research paper published in Cell Communication and Signaling (2022). On theSindex it has a DataRank of 0.494. It has been cited 26 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.494
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Cancer Institute of the National Institutes of Health
Grant: P30CA33572
NCI NIH HHS
Grant: P30 CA033572
National Institutes of Health
Grant: 5P30CA033572-27
Developmental Funds
Baum Family Foundation
FWCI
1.66
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 2 of Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression
Additional file 2 of Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression